CMS defends proposal to nix MCIT pathway, medtechs hold out hope

If the bid to repeal the breakthrough payment rule is finalized, the agency’s CMO committed to an alternative pathway that evaluates devices for Medicare patients potentially via clinical trials, outcome registries and real-world data.